Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Assets: 2022-2024

Historic Non-Current Assets for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $5.4 million.

  • Gossamer Bio's Non-Current Assets fell 26.92% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 26.92%. This contributed to the annual value of $5.4 million for FY2024, which is 0.13% up from last year.
  • Latest data reveals that Gossamer Bio reported Non-Current Assets of $5.4 million as of FY2024, which was up 0.13% from $5.4 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Non-Current Assets ranged from a high of $10.6 million in FY2022 and a low of $5.4 million during FY2023.
  • In the last 3 years, Gossamer Bio's Non-Current Assets had a median value of $5.4 million in 2024 and averaged $7.1 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 48.94% in 2023, then rose by 0.13% in 2024.
  • Yearly analysis of 3 years shows Gossamer Bio's Non-Current Assets stood at $10.6 million in 2022, then plummeted by 48.94% to $5.4 million in 2023, then rose by 0.13% to $5.4 million in 2024.